Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Finding the Universe of Workmanship: Individual Encounters in Imagination - 2Bolsonaro discharged from hospital and placed under house arrest
- 3Nexi expands alliance with PayPal
- 4Make your choice for a definitive Christmas place to get-away!
- 5How Mars 'punches above its weight' to influence Earth's climate
- Drones haven't won the fight in Ukraine. That matters as the West learns new ways of war.
- Meet the astronauts about to make history on flight around the moon
- 6 Trail blazing Bicycles for Rough terrain Undertakings
- Bolsonaro briefly leaves Brazilian prison for medical tests after a fall from his bed
- Sarkozy says he owes France 'the truth' as he challenges conviction over alleged Libya funding
- Top Smoothie Flavor: What's Your Mix?
- Bavarian leader questions Germany's Eurovision participation
- How to watch ‘The Traitors’ U.K. Season 4 from the U.S.
- ByHeart infant formula recall tied to botulism outbreak puts parents on edge
